MLYCD
Basic information
Region (hg38): 16:83899115-83951445
Links
Phenotypes
GenCC
Source:
- malonic aciduria (Definitive), mode of inheritance: AR
- malonic aciduria (Strong), mode of inheritance: AR
- malonic aciduria (Strong), mode of inheritance: AR
- malonic aciduria (Supportive), mode of inheritance: AR
- malonic aciduria (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Malonyl-CoA decarboxylase deficiency | AR | Biochemical; Cardiovascular | Dietary measures (low-fat, high-carbohydrate diet, with one report describing benefit from long-chain triglyceride restriction and medium-chain triglyceride supplementation) can normalize urinary organic acid excretion and prevent hypoglycemic episodes; During infectious/febrile illnesses, inpatient care to reduce morbidity and mortalitiy may be beneficial; Surveillance for cardiac manifestations may allow early management, which may be beneficial | Biochemical; Cardiovascular; Neurologic | 6145813; 3709568; 8259873; 10417274; 9869665; 10455107; 12955715; 16275149; 20549361; 22104738; 22778304; 31395333 |
ClinVar
This is a list of variants' phenotypes submitted to
- Deficiency of malonyl-CoA decarboxylase (37 variants)
- not provided (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MLYCD gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 237 | 244 | ||||
missense | 179 | 12 | 194 | |||
nonsense | 15 | 16 | ||||
start loss | 3 | |||||
frameshift | 21 | 21 | ||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 6 | |||||
splice region | 1 | 16 | 2 | 19 | ||
non coding | 21 | 59 | 28 | 108 | ||
Total | 38 | 9 | 204 | 308 | 36 |
Highest pathogenic variant AF is 0.0000394
Variants in MLYCD
This is a list of pathogenic ClinVar variants found in the MLYCD region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-83899122-C-A | not specified | Likely benign (Aug 01, 2017) | ||
16-83899134-T-C | Deficiency of malonyl-CoA decarboxylase | Uncertain significance (Jun 14, 2016) | ||
16-83899138-G-A | not specified • Deficiency of malonyl-CoA decarboxylase • MLYCD-related disorder | Benign/Likely benign (Mar 05, 2018) | ||
16-83899139-G-C | not specified | Likely benign (Aug 15, 2017) | ||
16-83899145-A-C | MLYCD-related disorder • Deficiency of malonyl-CoA decarboxylase | Pathogenic/Likely pathogenic (Aug 01, 2023) | ||
16-83899145-A-T | Deficiency of malonyl-CoA decarboxylase | Pathogenic/Likely pathogenic (Sep 03, 2023) | ||
16-83899146-T-C | Deficiency of malonyl-CoA decarboxylase | Pathogenic (Dec 02, 2023) | ||
16-83899151-G-A | Deficiency of malonyl-CoA decarboxylase • Inborn genetic diseases | Uncertain significance (Jan 18, 2023) | ||
16-83899152-G-A | Deficiency of malonyl-CoA decarboxylase | Conflicting classifications of pathogenicity (Jun 20, 2022) | ||
16-83899152-G-T | Deficiency of malonyl-CoA decarboxylase | Uncertain significance (Feb 17, 2022) | ||
16-83899153-C-G | Deficiency of malonyl-CoA decarboxylase | Likely benign (Feb 16, 2023) | ||
16-83899153-C-T | Deficiency of malonyl-CoA decarboxylase | Likely benign (Dec 31, 2023) | ||
16-83899156-C-T | not specified • Deficiency of malonyl-CoA decarboxylase | Likely benign (Sep 21, 2023) | ||
16-83899157-G-A | Deficiency of malonyl-CoA decarboxylase • not specified • MLYCD-related disorder | Conflicting classifications of pathogenicity (Aug 22, 2022) | ||
16-83899157-GGGCCAGGCTTGAC-G | Deficiency of malonyl-CoA decarboxylase | Pathogenic (Sep 19, 2023) | ||
16-83899158-G-C | Deficiency of malonyl-CoA decarboxylase | Uncertain significance (Aug 04, 2023) | ||
16-83899157-G-GGGCCAGGCTTGAC | Deficiency of malonyl-CoA decarboxylase | Pathogenic (Nov 05, 2023) | ||
16-83899162-A-G | Deficiency of malonyl-CoA decarboxylase | Likely benign (Nov 30, 2023) | ||
16-83899165-C-A | Deficiency of malonyl-CoA decarboxylase | Likely benign (Jan 12, 2024) | ||
16-83899165-C-G | Deficiency of malonyl-CoA decarboxylase | Likely benign (Dec 31, 2023) | ||
16-83899168-G-A | Deficiency of malonyl-CoA decarboxylase | Likely benign (Dec 06, 2023) | ||
16-83899171-G-A | Deficiency of malonyl-CoA decarboxylase | Likely benign (Oct 08, 2023) | ||
16-83899171-G-T | Deficiency of malonyl-CoA decarboxylase | Likely benign (Oct 15, 2023) | ||
16-83899174-C-G | Deficiency of malonyl-CoA decarboxylase | Likely benign (Jul 16, 2023) | ||
16-83899174-C-T | Deficiency of malonyl-CoA decarboxylase | Likely benign (Oct 08, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MLYCD | protein_coding | protein_coding | ENST00000262430 | 5 | 17057 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000648 | 0.980 | 124764 | 0 | 34 | 124798 | 0.000136 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.76 | 330 | 252 | 1.31 | 0.0000152 | 3102 |
Missense in Polyphen | 92 | 82.179 | 1.1195 | 877 | ||
Synonymous | -3.92 | 170 | 116 | 1.46 | 0.00000785 | 1050 |
Loss of Function | 2.06 | 8 | 17.3 | 0.464 | 8.35e-7 | 200 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000123 | 0.000122 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000164 | 0.000159 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000425 | 0.000425 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the conversion of malonyl-CoA to acetyl-CoA. In the fatty acid biosynthesis MCD selectively removes malonyl-CoA and thus assures that methyl-malonyl-CoA is the only chain elongating substrate for fatty acid synthase and that fatty acids with multiple methyl side chains are produced. In peroxisomes it may be involved in degrading intraperoxisomal malonyl-CoA, which is generated by the peroxisomal beta-oxidation of odd chain-length dicarboxylic fatty acids. Plays a role in the metabolic balance between glucose and lipid oxidation in muscle independent of alterations in insulin signaling. May play a role in controlling the extent of ischemic injury by promoting glucose oxidation. {ECO:0000269|PubMed:10455107, ECO:0000269|PubMed:15003260, ECO:0000269|PubMed:18314420, ECO:0000269|PubMed:23482565}.;
- Disease
- DISEASE: Malonyl-CoA decarboxylase deficiency (MLYCD deficiency) [MIM:248360]: Autosomal recessive disease characterized by abdominal pain, chronic constipation, episodic vomiting, metabolic acidosis and malonic aciduria. {ECO:0000269|PubMed:10417274}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- beta-Alanine metabolism - Homo sapiens (human);Propanoate metabolism - Homo sapiens (human);Peroxisome - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);Metformin Pathway, Pharmacodynamic;Malonyl-coa decarboxylase deficiency;Malonic Aciduria;Propanoate Metabolism;Methylmalonic Aciduria Due to Cobalamin-Related Disorders;Metabolism of lipids;Metabolism of proteins;Beta-oxidation of very long chain fatty acids;Peroxisomal lipid metabolism;Metabolism;Peroxisomal protein import;Fatty acid metabolism;Propanoate metabolism;Pyruvate metabolism
(Consensus)
Recessive Scores
- pRec
- 0.178
Haploinsufficiency Scores
- pHI
- 0.176
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.514
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.803
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mlycd
- Phenotype
- homeostasis/metabolism phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Gene ontology
- Biological process
- response to ischemia;acetyl-CoA biosynthetic process;protein targeting to peroxisome;fatty acid biosynthetic process;acyl-CoA metabolic process;regulation of glucose metabolic process;fatty acid oxidation;regulation of fatty acid beta-oxidation;positive regulation of fatty acid oxidation;malonyl-CoA catabolic process
- Cellular component
- cytoplasm;mitochondrion;mitochondrial matrix;peroxisome;peroxisomal matrix;cytosol
- Molecular function
- signaling receptor binding;identical protein binding;malonyl-CoA decarboxylase activity